The potential of protein kinase C as A target for anticancer treatment
- 1 January 1993
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 59 (3) , 257-280
- https://doi.org/10.1016/0163-7258(93)90070-t
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Dual modulation of protein kinase C activity by sphingosineBiochemical and Biophysical Research Communications, 1992
- Regulation of c-jun gene expression in HL-60 leukemia cells by 1-.beta.-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanismBiochemistry, 1991
- Induction of differentiation of HL-60 cells by protein kinase C inhibitor, K252aBiochemical and Biophysical Research Communications, 1990
- Characterization of specific binding sites for [3H]-staurosporine on various protein kinasesBiochemical and Biophysical Research Communications, 1990
- Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cellsBiochemical and Biophysical Research Communications, 1990
- Protein kinase C-γ is present in adriamycin resistant HL-60 leukemia cellsBiochemical and Biophysical Research Communications, 1990
- Inhibition of protein kinase C by sphingosine correlates with the presence of positive chargeBiochemical and Biophysical Research Communications, 1989
- The protein kinase inhibitor staurosporine, like phorbol esters, induces the association of protein kinase C with membranesBiochemical and Biophysical Research Communications, 1988
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1986
- Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptorBiochemical and Biophysical Research Communications, 1985